Second Affiliated Hospital Of Wenzhou Medical University

This study looked at whether the drug ustekinumab can help people with moderate to severe Crohn's disease reach 'deep remission' — meaning no symptoms, healed gut lining, and healed gut wall. Researchers followed 156 patients for 44 weeks and checked what factors helped predict t…

This study examined how differences in the BAFF gene might affect a person's risk of developing ulcerative colitis and how well they respond to the drug vedolizumab. Researchers analyzed genetic samples from 841 people with ulcerative colitis. The goal was to better understand th…

This study tested whether a special pacing technique in the heart's right ventricle can more accurately predict where certain rapid heartbeats originate, compared to standard ECG criteria. Researchers enrolled about 200 patients undergoing catheter ablation for ventricular arrhyt…

This completed study examined whether differences in the IL-7 receptor gene are linked to the risk of developing ulcerative colitis and how well patients respond to the drug vedolizumab. Researchers enrolled 898 people, including those with UC and healthy controls, and analyzed t…

This completed study looked at whether certain gene variations (BAFF) are linked to the risk and features of Crohn's disease. Researchers compared 824 people with and without the disease. The goal was to better understand the genetic factors involved, which could guide future res…

This study looked at 818 people with Crohn's disease to see if variations in the TNFSF4 gene are linked to the disease and how well patients respond to the drug ustekinumab. Researchers analyzed blood samples to find genetic patterns. The goal is to better understand why some pat…

This completed study looked at whether differences in the IL-7 receptor gene are linked to the risk of developing Crohn's disease and how well patients respond to the drug infliximab. Researchers analyzed genetic samples from 303 Crohn's patients and 514 healthy people. The goal …